Norethindrone Acetate
Sponsors
Regional Oncologic Center, Watson Pharmaceuticals, University of Southern California, Norton Healthcare, Boston Children's Hospital
Conditions
AIDSBleeding DisorderBreast CancerCBDContraceptive UsageEndometriosisEtonogestrel Contraceptive Implant, Bothersome BleedingHIV
Phase 2
Phase 3
Hormone Replacement Therapy and the Risk of Breast Cancer Recurrence in Women With Previous Early Stage Breast Cancer
CompletedNCT00003771
Start: 1997-09-30End: 2004-02-29Target: 1300Updated: 2013-09-20
Efficacy and Safety Study of Norethindrone Acetate Transdermal Delivery System in Contraception
CompletedNCT01140217
Start: 2010-05-31End: 2012-03-31Updated: 2013-09-19
Low-Dose Naltrexone in Combination With Standard Treatment in Women With Endometriosis
TerminatedNCT03970330
Start: 2020-01-16End: 2021-06-21Updated: 2022-11-03
Cannabidiol and Management of Endometriosis Pain
TerminatedNCT04527003
Start: 2020-12-04End: 2024-06-26Updated: 2025-04-04
Unknown Phase
The Effect of Protease Inhibitors on the Pharmacokinetics of Oral Norethindrone Contraception
CompletedNCT01667978
Start: 2012-06-30End: 2014-09-30Updated: 2015-08-20
Use of Norethindrone Acetate for Management of Bleeding Associated With the Etonogestrel Contraceptive Implant
CompletedNCT02353247
Start: 2015-08-31End: 2017-06-29Updated: 2022-03-16
The Effect of Dienogest vs. Norethindrone Acetate Treatment in Endometriosis
CompletedNCT05476172
Start: 2021-04-01End: 2023-06-30Updated: 2023-07-21
Heavy Menstrual Bleeding Progestin Treatment in Bleeding Disorders Study
RecruitingNCT05916469
Start: 2025-09-24End: 2029-06-30Target: 300Updated: 2025-12-17